All News

Vigabatrin, which is also sold under the brand name Sabril, is used to treat complex partial seizures in adult and pediatric patients.

This interoperable standard created to exchange information across the health care spectrum is gaining traction across the country.

BeiGene’s investigational Bruton’s tyrosine kinase (BTK) inhibitor, zanubrutinib (BGB-3111), has been granted Breakthrough Therapy designation by the FDA for the treatment of adults with mantle cell lymphoma (MCL) who have received at least 1 prior therapy.

Zanubrutinib (BGB-3111) is being investigated for the treatment of various B-cell malignancies, including mantle cell lymphoma.

Offering screening and referrals for mental health and peer support services can improve HIV outcomes in American Indian and Alaska Native patients.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Measles outbreaks are on the rise globally, and it is considered a public health crisis.

The committee is seeking detailed information and documents about some pharmaceutical companies' prescription drug pricing practices.

Application of core area methodology can help identify new hepatitis C cases and outbreaks and improve testing and treatment.

Approximately 94% of widely-used brand-name drugs on the market between 2005 and 2017 more than doubled in price during that time.

With this technology interface, the health care system could experience enhanced communication, efficiency, and regulatory compliance, which makes patient safety the ultimate benefit.

Officials with CVS Health have announced that Walmart has opted to leave CVS Caremark pharmacy benefit management commercial and Managed Medicaid retail pharmacy networks.

Officials with CVS Health have announced that Walmart has opted to leave the CVS Caremark pharmacy benefit management (PBM) commercial and Managed Medicaid retail pharmacy networks due to a disagreement over reimbursement increases.

CVS Caremark has requested that Walmart continue to fill prescriptions as an in-network participating pharmacy through April 30, 2019.

Cabozantinib’s new indication provides an additional therapeutic option for patients with advanced liver cancer who have been previously treated with sorafenib.

Patients with low-risk prostate cancer that harbors certain genetic alterations may have a higher risk of disease progression.

Meet our #ThankAPharmacist Twitter contest winner, Dr. Lee Golden.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

People who inject drugs may not accurately self-report HIV and antiretroviral drug status when entering an HIV prevention study.

The FDA has approved cabozantinib (Cabometyx, Exelixis) as a treatment for patients with hepatocellular carcinoma (HCC) who previously received sorafenib (Nexavar, Bayer).

The FDA has approved Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) use to include repeat vaccination to help protect against tetanus, diphtheria and pertussis.

Researchers identified an immune receptor that may lead to new drug treatments that target immune activation in patients with HIV.

Pharmacists are encouraged to discuss vaccination and prevention options with patients.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Trial comparing oral ponesimod versus teriflunomide (Aubagio) in relapsing multiple sclerosis will evaluate annualized relapse rate as well as other disease activity measures.

Researchers at Kaiser Permanente Washington conducted a qualitative pilot study to understand the experiences and decision-making women face as they contemplate the use of antinausea medications during pregnancy.

In this video, Ryan Forrey, PharmD, MS, FASHP is the Senior Manager of Market Development for Hazardous Drugs at BD, discusses USP 800 and surface contamination monitoring.